Drugs in the Pipeline
The placebo-controlled ORCA-2 study evaluated the safety and efficacy of cytisinicline as a treatment for smoking cessation in 810 adult smokers.
Manufacturers can now adequately supply the market with varenicline at or below the acceptable intake limit of 37ng per day.
Risk factors, prevention strategies, signs & symptoms, and general treatment options for deep vein thrombosis (DVT) and pulmonary embolism (PE).
MPR Weekly Dose Podcast
Treatment approved for hospitalized COVID patients; Update on Varenicline; Limits have been set for the Janssen vaccine; weekly dose podcast!